Skip to content

Systemic Lupus Erythematosus Susceptibility To 7 C1864732

Published: July 22, 2026Updated: August 20, 2026

Genetic markers linked to susceptibility for systemic lupus erythematosus, a chronic autoimmune disease that can involve skin, joints, and organs.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 20, 2026Editorial policy

Key facts at a glance

ICD-10
D89.9
ICD-11
3A00.0
Body system
immunologic
Severity
moderate
Chronic
true

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Warning signs - seek immediate care

!

Severe headache

Fatigue

(immunologic)

Generalized symptoms

(immunologic)

Noticeable symptoms that may vary in intensity over time.

Frequency: Common at all stages

Joint pain and swelling (arthritis)

(musculoskeletal)

Malar rash (butterfly rash)

(dermatologic)

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Antimalarial therapy

Hydroxychloroquine is typically recommended as a first-line agent for SLE management due to its immunomodulatory effects and ability to reduce disease flares and organ damage.

medication
2

Behavioral and nutritional therapy

Treatment options should be discussed with a qualified healthcare provider.

lifestyle
3

Photoprotection

Strict sun avoidance and broad-spectrum sunscreen use are essential as UV exposure can trigger disease flares and skin manifestations in SLE patients.

lifestyle

Additional treatment options

NSAIDs for symptom management

Non-steroidal anti-inflammatory medications may be used for management of joint pain, arthritis, and serositis symptoms in SLE patients.

medication

Regular disease activity assessment

Routine clinical visits with laboratory monitoring including urinalysis, complement levels, and anti-dsDNA antibodies help track disease progression and treatment response.

monitoring

Anti-inflammatory diet

Dietary modifications emphasizing omega-3 fatty acids, fresh vegetables, and reduced processed food intake may support overall disease management and reduce inflammation.

dietary

When to seek medical help

Recognize when you need immediate medical attention.

Schedule an appointment soon

Symptoms associated with this condition. Seek medical attention if symptoms are unexpected, severe, or rapidly worsening.- Contact your healthcare provider if symptoms persist or worsen. Seek emergency care for sudden severe symptoms.

Frequently asked questions

Common questions about this topic.

Q

What is Systemic Lupus Erythematosus Susceptibility To 7 C1864732?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Sources and references

Authoritative medical sources used to create this content.

1

Petri M, Orbai AM, Alarcon GS, et al. Derivation and validation of the Systemic Lupus International Collaborating Clinics classification criteria for systemic lupus erythematosus. Arthritis Rheum. 2012.

guideline2012
2

Lee YH, Song GG. Efficacy and safety of belimumab in patients with systemic lupus erythematosus: a meta-analysis. Clin Rheumatol. 2021.

meta_analysis2021
3

Tsokos GC. Autoimmunity and organ damage in systemic lupus erythematosus. Nat Rev Immunol. 2020.

review2020
4

Furie R, Rovin BH, Houssiau F, et al. Two-year randomized, controlled trial of belimumab in lupus nephritis. N Engl J Med. 2020.

clinical_trial2020

Medication Comparisons

Compare medications used to treat Systemic Lupus Erythematosus Susceptibility To 7 C1864732. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy